Edge Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
7,858.20
13,729.00
130,189.40
106,398.90
88,067.60
Total Accounts Receivable
459.00
-
-
-
-
Other Current Assets
212.60
307.60
1,081.10
954.60
986.70
Total Current Assets
8,529.80
14,036.60
131,270.50
107,353.50
89,054.30
Net Property, Plant & Equipment
140.00
1,444.00
2,767.00
3,418.10
3,423.90
Other Assets
63.90
1,566.10
55.20
142.90
142.90
Total Assets
8,733.80
17,046.70
134,092.70
110,914.40
92,621.10
ST Debt & Current Portion LT Debt
-
265.30
2,271.10
-
3,075.40
Other Current Liabilities
1,788.20
3,627.90
6,318.60
6,684.70
9,791.30
Total Current Liabilities
1,788.20
3,893.20
8,589.70
6,684.70
12,866.80
Long-Term Debt
-
2,527.70
3,025.40
14,953.10
17,382.90
Other Liabilities
1,614.50
1,671.10
-
-
-
Total Liabilities
3,402.70
8,092.00
11,615.10
21,637.90
30,249.70
Common Equity (Total)
15,349.60
27,833.70
122,477.50
89,276.60
62,371.40
Total Shareholders' Equity
5,331.00
8,954.70
122,477.50
89,276.60
62,371.40
Total Equity
5,331.00
8,954.70
122,477.50
89,276.60
62,371.40
Liabilities & Shareholders' Equity
8,733.80
17,046.70
134,092.70
110,914.40
92,621.10
Preferred Stock (Carrying Value)
20,680.70
36,788.40
-
-
-
About Edge Therapeutics
View Profile
